What is it about?
The study was an attempt to identify the role of Proline to Leucine change which seen in Toll-like Receptor Gene 9 (TLR9), in cervical cancer risk. We analyzed DNA of 110 cervical cancer patients and 141 healthy individuals using Polymerase Chain Reaction (PCR) based method to find out the difference of Proline to Leucine change between patients and healthy individuals. We found no change as all the study participants showed the presence of Proline genotype.
Featured Image
Why is it important?
This study was the first attempt to identify the association TLR9 Pro99Leu polymorphism towards cervical cancer risk.
Perspectives
I was happy to publish in F1000Reasearch as it provided a suitable platform to even share the small studies with scientific community rapidly which boosted my and my research team confidence.
Neeraj Jain
Charotar University of Science & Technology
Read the Original
This page is a summary of: Absence of toll-like receptor 9 Pro99Leu polymorphism in cervical cancer, F1000Research, May 2018, Faculty of 1000, Ltd.,
DOI: 10.12688/f1000research.14840.1.
You can read the full text:
Contributors
The following have contributed to this page
